We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > ranitidine

News List

FDA announces voluntary recall of Sandoz ranitidine capsules following detection of an impurity worldpharmanews
September 26, 2019
The U.S. Food and Drug Administration is alerting health care professionals and patients of a voluntary recall of 14 lots of prescription ranitidine capsules distributed by Sandoz Inc. ...
Maker Halts Distribution of Generic Zantac Due to Possible Carcinogen drugs
September 20, 2019
Novartis, the maker of a generic form of Zantac, said Wednesday it will stop selling the medicine after investigations suggested that generic and branded versions contain a known carcinogen.
NDMA discovered in samples of ranitidine medicines europeanpharmaceuticalreview
September 17, 2019
The EMA and the FDA are investigating some ranitidine medicines after they were found to contain NDMA, a probable human carcinogen.

Previous page 1 2 Next page